Milton H. Werner
2021
In 2021, Milton H. Werner earned a total compensation of $610.7K as President and Chief Executive Officer at Inhibikase Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $138,548 |
|---|---|
| Salary | $455,000 |
| Other | $17,107 |
| Total | $610,655 |
Werner received $455K in salary, accounting for 75% of the total pay in 2021.
Werner also received $138.5K in non-equity incentive plan and $17.1K in other compensation.
Rankings
In 2021, Milton H. Werner's compensation ranked 10,266th out of 12,415 executives tracked by ExecPay. In other words, Werner earned more than 17.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,266 out of 12,415 | 17th |
Division Manufacturing | 4,545 out of 5,505 | 17th |
Major group Chemicals And Allied Products | 2,036 out of 2,375 | 14th |
Industry group Drugs | 1,806 out of 2,096 | 14th |
Industry Biological Products, Except Diagnostic Substances | 396 out of 449 | 12th |
Source: SEC filing on May 5, 2023.
Werner's colleagues
We found one more compensation record of an executive who worked with Milton H. Werner at Inhibikase Therapeutics in 2021.
2021
Joseph Frattaroli
Inhibikase Therapeutics